A National Institute of Health-supported study found that statins, a class of cholesterol-lowering medications, may offset the high risk of cardiovascular disease in people living with HIV by more than a third, potentially preventing one in five major cardiovascular events or premature deaths in this population. People living with HIV can have up to a doubled risk for cardiovascular disease.
The findings, which were supported by NHLBI and the National Institute of Allergy and Infectious Diseases, published in the New England Journal of Medicine.
Media Coverage
|
MedPage Today
|
Medscape